Dosidal · Switzerland

Bilastin-Mepha Tabletten

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:68002 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 68002
atc: R06AX29
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2021-11-01
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: R06AX29
authorisation_number: 68002
form: TAB
holder: Mepha Pharma AG
holder_partner_nr: 1006155
it_number: 07.13.1.
name: Bilastin-Mepha Tabletten
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
1nOGjg_aOWJUZ7hVdaIDSqsJKoVCFxs_WbrMTWWD7EV5OAITU9OrXTWN0PwhXx2YXeyUEtLam8iesJcoktCPwQ
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:68002 · Related records in other markets · Dosidal